Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism

Early‐onset parkinsonism is frequently reported in connection with mutations in the parkin gene. In this study, we present the results of extensive genetic screening for parkin mutations in 111 community‐derived early‐onset parkinsonism patients (age of onset <50 years) from Germany with an overall mutation rate of 9.0%. Gene dosage alterations represented 67% of the mutations found, underlining the importance of quantitative analyses of parkin. In summary, parkin mutations accounted for a low but significant percentage of early‐onset parkinsonism patients in a community‐derived sample.

[1]  K. Huoponen,et al.  A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. , 1991, American journal of human genetics.

[2]  G. Hunter,et al.  Chorea as a paraneoplastic complication of Hodgkin's disease , 2004, Journal of Neuro-Oncology.

[3]  P. Vreken,et al.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060) , 1999, Journal of Inherited Metabolic Disease.

[4]  R. Moxley,et al.  Proximal myotonic myopathy (PROMM) and other proximal myotonic syndromes , 1998, Neuromuscular Disorders.

[5]  N. Hattori,et al.  An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.

[6]  L. Peltonen,et al.  A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia. , 1999, American journal of human genetics.

[7]  I. Nonaka,et al.  A new congenital muscular dystrophy with mitochondrial structural abnormalities , 1998, Muscle & nerve.

[8]  E. Haan,et al.  The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. , 1997, American journal of human genetics.

[9]  J. Honnorat,et al.  Anti-CV2 autoantibodies and paraneoplastic neurological syndromes , 2000, Clinical reviews in allergy & immunology.

[10]  D. Mackey,et al.  Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. , 1996, American journal of human genetics.

[11]  Stanley Fahn,et al.  Linkage mapping of dopa–responsive dystonia (DRD) to chromosome 14q , 1993, Nature Genetics.

[12]  H. Ichinose,et al.  Catecholamines and Serotonin Are Differently Regulated by Tetrahydrobiopterin , 2001, The Journal of Biological Chemistry.

[13]  A. Lang,et al.  Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene , 2000, Annals of neurology.

[14]  A. Engel,et al.  Localization of dystrophin and beta-spectrin in vacuolar myopathies. , 1993, The American journal of pathology.

[15]  A. Thompson,et al.  Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.

[16]  R. Wanders,et al.  Progressive Infantile Neurodegeneration Caused by 2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency: A Novel Inborn Error of Branched-Chain Fatty Acid and Isoleucine Metabolism , 2000, Pediatric Research.

[17]  J. Walker,et al.  Conservation of sequences of subunits of mitochondrial complex I and their relationships with other proteins. , 1992, Biochimica et biophysica acta.

[18]  A. Pitkänen,et al.  Recurrent seizures may cause hippocambal damage in temporal lobe epilepsy , 1998, Neurology.

[19]  Massimo Filippi,et al.  Brain and spinal cord MR in benign multiple sclerosis: a follow-up study , 1996, Journal of the Neurological Sciences.

[20]  U. Bonuccelli,et al.  Paraneoplastic choreic syndrome during non‐Hodgkin's lymphoma , 2000, Movement disorders : official journal of the Movement Disorder Society.

[21]  M. Villanova,et al.  X‐linked vacuolated myopathy: Complement membrane attack complex on surface membrane of injured muscle fibers , 1995, Annals of neurology.

[22]  S. Scherer,et al.  X‐linked vacuolar myopathies: Two separate loci and refined genetic mapping , 2000, Annals of neurology.

[23]  N. Miller,et al.  Leber's hereditary optic neu-ropathy. Clinical manifestations of the 14484 mutation , 1993 .

[24]  J. Lonnqvist,et al.  Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA , 1997, Neurology.

[25]  B. Clark,et al.  X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. , 1991, The Journal of pediatrics.

[26]  F. Muntoni,et al.  Familial cardiomyopathy, mental retardation and myopathy associated with desmin-type intermediate filaments , 1994, Neuromuscular Disorders.

[27]  O. Hornykiewicz.  Biochemical aspects of Parkinson's disease , 1998, Neurology.

[28]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[29]  A. Amato.  Acid maltase deficiency and related myopathies. , 2000, Neurologic clinics.

[30]  S. Kish,et al.  Dopa‐responsive dystonia: Recent advances and remaining issues to be addressed , 1999, Movement disorders : official journal of the Movement Disorder Society.

[31]  K. Marder,et al.  Risk of Parkinson's disease among first-degree relatives , 1996, Neurology.

[32]  Y. Goto,et al.  Two pathogenic point mutations exist in the authentic mitochondrial genome, not in the nuclear pseudogene , 2000, Journal of Human Genetics.

[33]  S. Dimauro,et al.  Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. , 1999, Journal of lipid research.

[34]  R. Schutgens.  The metabolic and molecular bases of inherited disease, seventh edition—3-volume set Edited by Charles R. Scriver, Arthur L. Beaudet, William S. Sly, and David Valle. New York, McGraw-Hill, 1995, $285.84 (xxxvi + 4605 pages and 93-page index), ISBN 0-07909-826-6 , 1995, Trends in Endocrinology & Metabolism.

[35]  P. Dean,et al.  X‐Linked myopathy with excessive autophagy: A new hereditary muscle disease , 1988, Annals of neurology.

[36]  G. Barker,et al.  MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[37]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[38]  D. Turnbull,et al.  Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.

[39]  S J Kish,et al.  Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia , 1999, Neurology.

[40]  M. L. Greenberg,et al.  The biosynthesis and functional role of cardiolipin. , 2000, Progress in lipid research.

[41]  Massimo Filippi,et al.  A spinal cord MRI study of benign and secondary progressive multiple sclerosis , 2004, Journal of Neurology.

[42]  C. Lucchinetti,et al.  Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies , 1998, Neurology.

[43]  T. Sutula.  Experimental Models of Temporal Lobe Epilepsy: New Insights from the Study of Kindling and Synaptic Reorganization , 1990, Epilepsia.

[44]  Graeme D Jackson,et al.  Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients , 1998, The Lancet.

[45]  C. Marsden,et al.  Dopa‐responsive dystonia: A clinical and molecular genetic study , 1998, Annals of neurology.

[46]  E. Zrenner,et al.  Leber’s hereditary optic neuropathy: clinical and molecular genetic findings in a patient with a new mutation in the ND6 gene , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[47]  E. Holme,et al.  Mitochondrial DNA Deletions in Muscle Fibers in Inclusion Body Myositis , 1995, Journal of neuropathology and experimental neurology.

[48]  R. Knobler,et al.  Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. , 1995, Radiology.

[49]  F. Barkhof,et al.  Diffuse signal abnormalities in the spinal cord in multiple sclerosis: Direct postmortem in situ magnetic resonance imaging correlated with in vitro high‐resolution magnetic resonance imaging and histopathology , 2002, Annals of neurology.

[50]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[51]  O. Søvik,et al.  3-Oxothiolase Activities and [14C]-2-Methylbutanoic Acid Incorporation in Cultured Fibroblasts from 13 Cases of Suspected 3-Oxothiolase Deficiency , 1990, Pediatric Research.

[52]  J. Berden,et al.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes , 1983, Journal of the Neurological Sciences.

[53]  C. Goetz,et al.  Ballistic-choreic movements as the presenting feature of renal cancer. , 2001, Archives of neurology.

[54]  V. Lennon.  The case for a descriptive generic nomenclature , 1994, Neurology.

[55]  A. Kishore,et al.  Striatal D2 receptors in symptomatic and asymptomatic carriers of dopa-responsive dystonia measured with [11C]-raclopride and positron-emission tomography , 1998, Neurology.

[56]  T. Kurashige,et al.  Proposal for Revised Classification of Epilepsies and Epileptic Syndromes , 1989, No to hattatsu = Brain and development.

[57]  Á. Chamorro,et al.  Chorea in the Antiphospholipid Syndrome: Clinical, Radiologic, and Immunologic Characteristics of 50 Patients from Our Clinics and the Recent Literature , 1997, Medicine.

[58]  J. Rashbass.  Online Mendelian Inheritance in Man. , 1995, Trends in genetics : TIG.

[59]  E. Holme,et al.  Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia , 1996, Annals of neurology.

[60]  J. Vockley,et al.  2-Methylbutyryl-Coenzyme A Dehydrogenase Deficiency: A New Inborn Error of L-Isoleucine Metabolism , 2000, Pediatric Research.

[61]  S. Dimauro,et al.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) , 2000, Nature.

[62]  J. Parks,et al.  A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. , 1989, The New England journal of medicine.

[63]  Ari Syngeniotis,et al.  Comparison of Hippocampal Volumetry at 1.5 Tesla and at 3 Tesla , 2001, Epilepsia.

[64]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[65]  T. Fukushima,et al.  Analysis of reduced forms of biopterin in biological tissues and fluids. , 1980, Analytical biochemistry.

[66]  F. Edward Dudek,et al.  Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy , 1998, Epilepsy Research.

[67]  M. Schlame,et al.  Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. , 1990, The Biochemical journal.

[68]  F. Barkhof,et al.  Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. , 2001, Brain : a journal of neurology.

[69]  T. Resnick,et al.  Magnetic Resonance Imaging Evidence of Hippocampal Sclerosis in Progression: A Case Report , 1994, Epilepsia.

[70]  I. Nishino.  [X-linked myopathy with excessive autophagy]. , 2001, Ryoikibetsu shokogun shirizu.

[71]  E. Benarroch,et al.  CRMP‐5 neuronal autoantibody: Marker of lung cancer and thymoma‐related autoimmunity , 2001, Annals of neurology.

[72]  E. Schon,et al.  Detection and analysis of mitochondrial DNA and RNA in muscle by in situ hybridization and single-fiber PCR. , 1996, Methods in enzymology.

[73]  V. Lennon,et al.  New Purkinje cell antibody (PCA‐2): Marker of lung cancer–related neurological autoimmunity , 2000, Annals of neurology.

[74]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[75]  Y. Agid,et al.  Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? , 2000, Brain : a journal of neurology.

[76]  C. Jack,et al.  Progressive hippocampal atrophy in chronic intractable temporal lobe epilepsy , 1999, Annals of neurology.

[77]  Y. Agid,et al.  A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. , 1999, Human molecular genetics.

[78]  Christine Klein,et al.  Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism , 2001, Neurogenetics.

[79]  G. Comi,et al.  Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria , 2001, Nature Genetics.

[80]  E. Maestrini,et al.  A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.

[81]  T. Dawson,et al.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[82]  S. Dimauro,et al.  Lysosomal glycogen storage disease with normal acid maltase , 1981, Neurology.

[83]  A. Druschky,et al.  Chorea resulting from paraneoplastic encephalitis , 1997, Movement disorders : official journal of the Movement Disorder Society.

[84]  S. Blumen,et al.  Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin gene. , 1999, Neurology.

[85]  N. Shimizu,et al.  A human muscle adenine nucleotide translocator gene has four exons, is located on chromosome 4, and is differentially expressed. , 1989, The Journal of biological chemistry.

[86]  E. Bertini,et al.  Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA , 1991, Neurology.

[87]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[88]  Frederick Andermann,et al.  Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy , 1999, Annals of neurology.

[89]  R. Levine,et al.  Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia , 1998, Neurology.

[90]  N. Newman,et al.  Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. , 1992, Journal of clinical neuro-ophthalmology.

[91]  Clifford R. Jack,et al.  Quantitative MRI hippocampal volumes: association with onset and duration of epilepsy, and febrile convulsions in temporal lobectomy patients , 1993, Epilepsy Research.

[92]  C. Ansevin.  Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. , 2000, Neurology.

[93]  A. Quattrone,et al.  Mild Non-lesional Temporal Lobe Epilepsy: A Common, Unrecognized Disorder with Onset in Adulthood , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[94]  W. Gibb,et al.  Dopa‐responsive dystonia: Pathological and biochemical observations in a case , 1994, Annals of neurology.

[95]  G. Jackson,et al.  Hippocampal sclerosis following brief generalized seizures in adulthood , 2001, Neurology.

[96]  L. Grivell,et al.  Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. , 2000, Biochemical and biophysical research communications.

[97]  Nobutaka Hattori,et al.  Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.

[98]  Bonifati,et al.  Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.

[99]  P. S. St George-Hyslop,et al.  Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia , 1998, Neurology.

[100]  K. Thielen,et al.  Multiple sclerosis of the spinal cord: magnetic resonance appearance. , 1996, Journal of computer assisted tomography.

[101]  P. Scheltens,et al.  MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.

[102]  M. Villanova,et al.  X‐linked vacuolated myopathy: Membrane attack complex deposition on muscle fiber membranes with calcium accumulation on sarcolemma , 1997, Annals of neurology.

[103]  L. Peltonen,et al.  An autosomal locus predisposing to deletions of mitochondrial DNA , 1995, Nature Genetics.

[104]  D. Wallace,et al.  Functional Analysis of Lymphoblast and Cybrid Mitochondria Containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutation* , 2000, The Journal of Biological Chemistry.

[105]  M. Brin,et al.  Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspects. , 1999, Genetic testing.

[106]  S. Kish,et al.  Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations , 2001, Neurology.

[107]  T. Fukao,et al.  The clinical phenotype and outcome of mitochondrial acetoacetyl-CoA thiolase deficiency (beta-ketothiolase or T2 deficiency) in 26 enzymatically proved and mutation-defined patients. , 2001, Molecular genetics and metabolism.

[108]  A. de la Chapelle,et al.  Linkage studies in a new X-linked myopathy, suggesting exclusion of DMD locus and tentative assignment to distal Xq. , 1988, American journal of human genetics.

[109]  S. Dimauro,et al.  mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. , 1991, American journal of human genetics.

[110]  M Kokaia,et al.  Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[111]  M. Magistris,et al.  Paraneoplastic anti‐CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy , 2001, Annals of neurology.

[112]  G. Jackson,et al.  Men may be more vulnerable to seizure-associated brain damage , 2000, Neurology.

[113]  F. Barkhof,et al.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.

[114]  T. Ashizawa,et al.  The Myotonic Dystrophies , 2014 .

[115]  J. Cavazos,et al.  Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions , 1998, Annals of neurology.

[116]  P. Vieregge,et al.  Personality traits in young patients with Parkinson's disease , 2001, Acta neurologica Scandinavica.

[117]  A. Bakheit,et al.  Paraneoplastic limbic encephalitis: clinico-pathological correlations. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[118]  G. Bartzokis,et al.  Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. , 1993, Magnetic resonance imaging.

[119]  N. Howell,et al.  Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. , 1991, American journal of human genetics.

[120]  E Stålberg,et al.  Quantitative motor unit potential analysis. , 1996, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[121]  C. Broeckhoven,et al.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions , 2001, Nature Genetics.

[122]  T. Nygaard,et al.  Dopa-responsive dystonia : delineation of the clinical syndrome and clues to pathogenesis , 1993 .

[123]  G. Jackson,et al.  Hippocampal Sclerosis: Development in Adult Life , 1999, Developmental Neuroscience.

[124]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[125]  S. Tsuji,et al.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.

[126]  J. Dalmau,et al.  Response to cancer therapy in a patient with a paraneoplastic choreiform disorder , 2001, Neurology.

[127]  A. Torroni,et al.  Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. , 1992, The Journal of biological chemistry.

[128]  N. Shimizu,et al.  Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals , 1998, Annals of neurology.

[129]  G. Gascon,et al.  3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms , 1994, Brain and Development.

[130]  P. O'Suilleabhain,et al.  Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. , 1995, The New England journal of medicine.

[131]  S. Kish,et al.  Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations , 1998, Annals of neurology.

[132]  A. Lang,et al.  The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. , 2001, Human molecular genetics.

[133]  D. Figarella-Branger,et al.  Linkage of X-linked myopathy with excessive autophagy (XMEA) to Xq28 , 2000, European Journal of Human Genetics.

[134]  Bert Vogelstein,et al.  Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.

[135]  A. Connelly,et al.  Longitudinal Quantitative Hippocampal Magnetic Resonance Imaging Study of Adults with Newly Diagnosed Partial Seizures: One‐Year Follow‐Up Results , 1998, Epilepsia.

[136]  H. Sahm,et al.  The same domain motif for ubiquinone reduction in mitochondrial or chloroplast NADH dehydrogenase and bacterial glucose dehydrogenase , 1990, FEBS letters.

[137]  S. Dimauro,et al.  Adult acid maltase deficiency , 1993, Muscle & nerve.

[138]  X. Breakefield,et al.  Parkin deletions in a family with adult‐onset, tremor‐dominant parkinsonism: Expanding the phenotype , 2000, Annals of neurology.

[139]  H. Schulz,et al.  Short-chain 3-hydroxy-2-methylacyl-CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism. , 1995, Archives of biochemistry and biophysics.

[140]  Y. Piao,et al.  Chorea resulting from paraneoplastic striatal encephalitis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[141]  J. Penney,et al.  Chorea and dystonia: A remote effect of carcinoma , 1988, Movement disorders : official journal of the Movement Disorder Society.

[142]  M. Farrer,et al.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. , 2001, American journal of human genetics.

[143]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[144]  A. Ghelli,et al.  Biochemical features of mtDNA 14484 (ND6/m64V) point mutation associated with Leber's hereditary optic neuropathy , 1999, Annals of neurology.

[145]  B. Dahms,et al.  An X-linked recessive cardiomyopathy with abnormal mitochondria. , 1979, Pediatrics.

[146]  R. S. Gunasekera,et al.  Tetrahydrobiopterin and Biogenic Amine Metabolism in the hph‐1 Mouse , 1996, Journal of neurochemistry.

[147]  L. Peltonen,et al.  Role of adenine nucleotide translocator 1 in mtDNA maintenance. , 2000, Science.

[148]  B. Dworniczak,et al.  A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome , 2004, Human Genetics.

[149]  D. Turnbull,et al.  The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. , 2001, Brain : a journal of neurology.

[150]  Y. Imai,et al.  Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.